Peptide Array Autoimmune Disease Diagnosis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for diagnosing autoimmune diseases, such as systemic lupus erythematosus, are inadequate due to the lack of reliable biomarkers, leading to inaccurate diagnoses and delayed treatment, which can result in cumulative chronic organ damage.
Innovation Solution
The use of peptide arrays comprising thousands of distinct peptides to detect binding patterns of antibodies in patient samples, generating immunosignatures that correlate with disease activity, allowing for accurate determination of autoimmune disease presence and severity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional diagnostic methods are used for autoimmune diseases, then the diagnostic process is simple, but the diagnostic accuracy is low and treatment is delayed
Solution Approach 1:
The diagnostic system segments the complex task of autoimmune disease detection into multiple components: a peptide array with thousands of distinct peptides, a sample processing system, and a pattern recognition system. Each component performs a specific function, with the peptide array providing comprehensive antigen coverage and the pattern recognition system analyzing binding signatures to determine disease activity.
Solution Approach 2:
The peptide array serves multiple functions simultaneously: it acts as a comprehensive antigen library, a detection platform for antibodies, and a diagnostic tool for determining disease activity status. The same array structure enables detection of various autoimmune conditions and monitoring of disease progression, making it a multi-functional diagnostic system.
2Reliability
If a peptide array with thousands of distinct peptides is used, then the sensitivity and specificity of disease detection is improved, but the device complexity and manufacturing difficulty increase
Solution Approach 1:
The system merges multiple diagnostic functions into a single integrated peptide array platform. The array combines thousands of distinct peptides in a standardized format, allowing simultaneous detection of multiple autoimmune conditions and disease activity assessment in one test, thereby improving reliability while managing manufacturing complexity through consolidation.
Solution Approach 2:
The invention optimizes the peptide array by controlling parameters such as peptide length (5-20 amino acids), peptide concentration, array density, and peptide sequences to ensure reliable detection. By carefully selecting and standardizing these parameters, the system achieves high diagnostic reliability while maintaining manufacturability through standardized production protocols.
3Measurement precision
If antibody binding patterns are analyzed to determine disease activity, then the monitoring accuracy is improved, but the time required for analysis increases
Solution Approach 1:
The system extracts and analyzes only the most relevant binding patterns from the complex antibody-peptide interactions. By identifying and focusing on specific peptide binding signatures that are most indicative of disease activity, the system achieves high monitoring accuracy while reducing analysis time compared to comprehensive analysis of all possible binding patterns.
Solution Approach 2:
The diagnostic system incorporates feedback mechanisms where binding patterns are compared against reference data and clinical information. This feedback loop allows the system to refine its analysis and provide accurate disease activity monitoring while optimizing analysis time through iterative improvement and machine learning algorithms that become increasingly efficient with each use.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach provides a sensitive and specific method for diagnosing autoimmune diseases by identifying differential binding patterns, improving diagnostic accuracy and monitoring disease activity, potentially leading to better therapeutic outcomes.
Implementation Method 1
detecting the binding of antibodies present in the sample to a set of peptides on the peptide array
Data Source
AI summary
Provided herein are methods, assays and devices for the detection and diagnosis of autoimmune diseases, including systemic lupus erythematosus. The methods, assays and devices provided herein analyzes binding patterns of peripheral-blood antibodies on peptide array that correlates well with current systemic lupus erythematosus clinical assessment standards.